Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000494232 | SCV000583061 | likely benign | not provided | 2020-10-13 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV000764180 | SCV000895182 | uncertain significance | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000494232 | SCV001143326 | uncertain significance | not provided | 2018-12-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001212290 | SCV001383870 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-10-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000494232 | SCV002543883 | uncertain significance | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | CACNA1A: PP2 |
Revvity Omics, |
RCV000494232 | SCV003830267 | uncertain significance | not provided | 2020-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023314 | SCV004916239 | likely benign | Inborn genetic diseases | 2023-12-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |